Portfolio Lab

Frontline plc

  • Stock
  • Ticker FRO
  • ISIN CY0200352116
  • NYSE
  • US listing in dollars

Industrials · Logistics and transportation · Cyprus

$45.21 +1.03%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Frontline plc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

FROGlobal equities (VT)

$10,000 grew to $120,206. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −52.0% in 04/2025, measured from the peak in 05/2024. It took 20 months to get back to the old peak.

1-year return
+109.0%
5-year return p.a.
+58.1%
10-year return p.a.
+28.2%
Volatility p.a.
47.8%
Largest decline
−52.0%

Financial statements

Amounts in $ millions from the company's annual financial reports, earnings per share in $ per ordinary share

Fiscal year20212022202320242025
Income statement
Revenue––1,8022,0501,965
Operating income8.5446747782599
Net income-15476656496379
Earnings per share-0.082.222.952.231.70
Balance sheet
Total assets4,1074,7685,8836,2215,754
Liabilities2,4652,5093,6053,8813,243
Equity1,6422,2602,2772,3402,511
Cash113255308414251
Long-term debt2,1272,1123,1943,2842,747
Cash flow
Operating cash flow85385856736682
Capital expenditure-474-336-1,631-915-13
Free cash flow-38950-775-179670

Annual returns

Best year 2019 at +134.6%, weakest 2020 at −41.3%. 6 of 9 full years were positive. * partial year.

Key metrics

Key figures as of 21 Nov 2026 from the company's latest annual financial report, amounts converted to US dollars at the ECB reference rate. Valuation and market cap appear only where price and earnings per share reliably refer to the same share.

Valuation

Market cap
€9.1bn
Market cap in trading currency
$10.1bn
Enterprise value
$12.9bn
P/E
26.6
P/S
5.13
P/B
4.01
EV/Sales
6.56
EV/EBITDA
–
Earnings yield
3.8%
FCF yield
6.6%

Results (latest fiscal year)

Revenue
$1.97bn
Gross profit
–
EBITDA
–
Net income
$379m
Earnings per share
$1.70
Revenue growth
−4.2%
Earnings growth
−23.5%

Profitability

Gross margin
–
Operating margin
30.5%
Net margin
19.3%
Return on equity
15.6%
Return on assets
6.6%

Balance sheet and cash flow

Cash
$251m
Financial debt
$3.07bn
Debt/equity %
122
Current ratio
1.43
Book value per share
$11.26
Operating cash flow
$682m
Free cash flow
$670m

Dividend

Dividend yield
13.67%
Dividend (12 months)
$6.18
Yield (12 months)
13.67%
Payout ratio
55%
Ex-dividend date
18 Sep 2026

Shares and trading

Shares outstanding
223m
Volume
4.56m
Avg. volume 3 months
3.97m
Relative volume
1.2

Price and technicals

Price
$45.21
1 day
+1.0%
52-week high
$59.19
52-week low
$20.58
Distance to 52-week high
−23.6%
Distance to 52-week low
+119.7%
Distance to 50-day line
−10.8%
Distance to 200-day line
+11.2%
RSI (14)
40
Volatility 1M
61.2%

Performance

1 week
−3.7%
1 month
−11.7%
3 months
+2.6%
6 months
+21.8%
YTD
+107.2%
1 year
+79.4%

Dates

Fiscal year end
31 Dec 2025

Frequently asked questions

How has FRO performed since 11/2016?

$10,000 grew to $120,206 by 20 Nov 2026, which is +28.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is FRO?

Volatility was 47.8% per year, measured on monthly returns. The largest decline from a peak was −52.0%, with the low in 04/2025.

How does FRO compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, FRO returned +28.2% at 47.8%. The correlation of monthly returns was 0.09; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Key figures and financial statements calculated from the company's annual financial reports, without guarantee; key figures converted to US dollars at the ECB reference rate, statements in the currency of the report.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Frontline plc (FRO): Return and risk | Portfolio Lab